Vitro swings to 2Q FY26 net profit of US$44 million; net sales rise 27.7% vs 2Q FY25

• Vitro posted 2Q26 net income of US$44 million, including a US$28 million net financial gain and US$17 million tax benefit.
• Consolidated net sales rose 27.7% versus 2Q25, driven mainly by higher value of services provided.
• UAFIR Flujo increased from 2Q25 on higher sales and administrative efficiencies in cost of sales and general expenses.
• Cash ended the quarter at US$9 million versus US$10 million in the prior quarter, reflecting a corporate restructuring.
• Total debt stood at US$112 million, including US$50 million in short-term loans plus shareholder payables and right-of-use lease liabilities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vitro SAB de CV published the original content used to generate this news brief on July 22, 2026, and is solely responsible for the information contained therein.